{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:31:44Z","timestamp":1771039904410,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging. Inform. med."],"DOI":"10.1007\/s10278-024-01163-1","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T16:02:09Z","timestamp":1721232129000},"page":"148-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metastatic Lung Adenocarcinomas: Development and Evaluation of Radiomic-Based Methods to Measure Baseline Intra-Patient Inter-Tumor Lesion Heterogeneity"],"prefix":"10.1007","volume":"38","author":[{"given":"Mathilde","family":"Lafon","sequence":"first","affiliation":[]},{"given":"Sophie","family":"Cousin","sequence":"additional","affiliation":[]},{"given":"M\u00e9lissa","family":"Alam\u00e9","sequence":"additional","affiliation":[]},{"given":"St\u00e9phanie","family":"Nougaret","sequence":"additional","affiliation":[]},{"given":"Antoine","family":"Italiano","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-6482","authenticated-orcid":false,"given":"Amandine","family":"Cromb\u00e9","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"1163_CR1","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","volume":"7","author":"AK Ganti","year":"2021","unstructured":"Ganti AK, Klein AB, Cotarla I, et al (2021) Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. JAMA Oncol 7:1824\u20131832. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4932","journal-title":"JAMA Oncol"},{"key":"1163_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT (2018) Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 15:81\u201394. https:\/\/doi.org\/10.1038\/nrclinonc.2017.166","journal-title":"Nat Rev Clin Oncol"},{"key":"1163_CR3","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749\u2013762. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141","journal-title":"Nat Rev Clin Oncol"},{"key":"1163_CR4","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1002\/mp.12208","volume":"44","author":"M Alilou","year":"2017","unstructured":"Alilou M, Beig N, Orooji M, et al (2017) An integrated segmentation and shape-based classification scheme for distinguishing adenocarcinomas from granulomas on lung CT. Med Phys 44:3556\u20133569. https:\/\/doi.org\/10.1002\/mp.12208","journal-title":"Med Phys"},{"key":"1163_CR5","doi-asserted-by":"publisher","first-page":"065005","DOI":"10.1088\/1361-6560\/aaafab","volume":"63","author":"S-J Tu","year":"2018","unstructured":"Tu S-J, Wang C-W, Pan K-T, et al (2018) Localized thin-section CT with radiomics feature extraction and machine learning to classify early-detected pulmonary nodules from lung cancer screening. Phys Med Biol 63:065005. https:\/\/doi.org\/10.1088\/1361-6560\/aaafab","journal-title":"Phys Med Biol"},{"key":"1163_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiol.2018180910","volume":"290","author":"N Beig","year":"2019","unstructured":"Beig N, Khorrami M, Alilou M, et al (2019) Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas. Radiology 290:783\u2013792. https:\/\/doi.org\/10.1148\/radiol.2018180910","journal-title":"Radiology"},{"key":"1163_CR7","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1002\/mp.13592","volume":"46","author":"J Uthoff","year":"2019","unstructured":"Uthoff J, Stephens MJ, Newell JD, et al (2019) Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT. Med Phys 46:3207\u20133216. https:\/\/doi.org\/10.1002\/mp.13592","journal-title":"Med Phys"},{"key":"1163_CR8","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1038\/s41598-019-38831-0","volume":"9","author":"D Cherezov","year":"2019","unstructured":"Cherezov D, Goldgof D, Hall L, et al (2019) Revealing Tumor Habitats from Texture Heterogeneity Analysis for Classification of Lung Cancer Malignancy and Aggressiveness. Sci Rep 9:4500. https:\/\/doi.org\/10.1038\/s41598-019-38831-0","journal-title":"Sci Rep"},{"key":"1163_CR9","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1007\/s00259-021-05242-1","volume":"48","author":"G Wu","year":"2021","unstructured":"Wu G, Jochems A, Refaee T, et al (2021) Structural and functional radiomics for lung cancer. Eur J Nucl Med Mol Imaging 48:3961\u20133974. https:\/\/doi.org\/10.1007\/s00259-021-05242-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1163_CR10","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1158\/0008-5472.CAN-17-0122","volume":"77","author":"E Rios Velazquez","year":"2017","unstructured":"Rios Velazquez E, Parmar C, Liu Y, et al (2017) Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer. Cancer Res 77:3922\u20133930. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0122","journal-title":"Cancer Res"},{"key":"1163_CR11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1158\/0008-5472.CAN-20-0999","volume":"81","author":"G Rossi","year":"2021","unstructured":"Rossi G, Barabino E, Fedeli A, et al (2021) Radiomic Detection of EGFR Mutations in NSCLC. Cancer Res 81:724\u2013731. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0999","journal-title":"Cancer Res"},{"key":"1163_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/1759-7714.13352","volume":"11","author":"J Yoon","year":"2020","unstructured":"Yoon J, Suh YJ, Han K, et al (2020) Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas. Thorac Cancer 11:993\u20131004. https:\/\/doi.org\/10.1111\/1759-7714.13352","journal-title":"Thorac Cancer"},{"key":"1163_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","volume":"19","author":"R Sun","year":"2018","unstructured":"Sun R, Limkin EJ, Vakalopoulou M, et al (2018) A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol 19:1180\u20131191. https:\/\/doi.org\/10.1016\/S1470-2045(18)30413-3","journal-title":"Lancet Oncol"},{"key":"1163_CR14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00259-019-04625-9","volume":"47","author":"W Mu","year":"2020","unstructured":"Mu W, Tunali I, Gray JE, et al (2020) Radiomics of 18F-FDG PET\/CT images predicts clinical benefit of advanced NSCLC patients to checkpoint blockade immunotherapy. Eur J Nucl Med Mol Imaging 47:1168\u20131182. https:\/\/doi.org\/10.1007\/s00259-019-04625-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1163_CR15","doi-asserted-by":"publisher","first-page":"e180012","DOI":"10.1148\/ryai.2019180012","volume":"1","author":"M Khorrami","year":"2019","unstructured":"Khorrami M, Khunger M, Zagouras A, et al (2019) Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma. Radiol Artif Intell 1:e180012. https:\/\/doi.org\/10.1148\/ryai.2019180012","journal-title":"Radiol Artif Intell"},{"key":"1163_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1148\/radiol.211582","volume":"303","author":"R Perez-Johnston","year":"2022","unstructured":"Perez-Johnston R, Araujo-Filho JA, Connolly JG, et al (2022) CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes. Radiology 303:664\u2013672. https:\/\/doi.org\/10.1148\/radiol.211582","journal-title":"Radiology"},{"key":"1163_CR17","doi-asserted-by":"publisher","first-page":"7902","DOI":"10.1007\/s00330-023-09709-7","volume":"33","author":"Y Fan","year":"2023","unstructured":"Fan Y, Wang X, Dong Y, et al (2023) Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC. Eur Radiol 33:7902\u20137912. https:\/\/doi.org\/10.1007\/s00330-023-09709-7","journal-title":"Eur Radiol"},{"key":"1163_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.crad.2024.02.016","volume":"79","author":"H Qi","year":"2024","unstructured":"Qi H, Hou Y, Zheng Z, et al (2024) MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis. Clin Radiol 79:515\u2013525. https:\/\/doi.org\/10.1016\/j.crad.2024.02.016","journal-title":"Clin Radiol"},{"key":"1163_CR19","doi-asserted-by":"publisher","first-page":"1373330","DOI":"10.3389\/fimmu.2024.1373330","volume":"15","author":"J Xu","year":"2024","unstructured":"Xu J, Wang P, Li Y, et al (2024) Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer. Front Immunol 15:1373330. https:\/\/doi.org\/10.3389\/fimmu.2024.1373330","journal-title":"Front Immunol"},{"key":"1163_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12885-024-12306-6","volume":"24","author":"Z Deng","year":"2024","unstructured":"Deng Z, Liu X, Wu R, et al (2024) Ultrasound-based radiomics machine learning models for diagnosing cervical lymph node metastasis in patients with non-small cell lung cancer: a multicentre study. BMC Cancer 24:536. https:\/\/doi.org\/10.1186\/s12885-024-12306-6","journal-title":"BMC Cancer"},{"key":"1163_CR21","doi-asserted-by":"publisher","first-page":"103177","DOI":"10.1016\/j.ejmp.2023.103177","volume":"116","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Wang H, Yuan W, et al (2023) Combined radiomics of primary tumour and bone metastasis improve the prediction of EGFR mutation status and response to EGFR-TKI therapy for NSCLC. Phys Medica PM Int J Devoted Appl Phys Med Biol Off J Ital Assoc Biomed Phys AIFB 116:103177. https:\/\/doi.org\/10.1016\/j.ejmp.2023.103177","journal-title":"Phys Medica PM Int J Devoted Appl Phys Med Biol Off J Ital Assoc Biomed Phys AIFB"},{"key":"1163_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/RCT.0000000000001591","author":"Y Hu","year":"2024","unstructured":"Hu Y, Geng Y, Wang H, et al (2024) Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis. J Comput Assist Tomogr. https:\/\/doi.org\/10.1097\/RCT.0000000000001591","journal-title":"J Comput Assist Tomogr"},{"key":"1163_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"1990","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer Oxf Engl 1990 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer Oxf Engl"},{"key":"1163_CR24","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S, et al (2018) LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity. Cancer Res 78:4786\u20134789. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0125","journal-title":"Cancer Res"},{"key":"1163_CR25","unstructured":"Kendall MG, Gibbons JD (1990) Rank correlation methods. E. Arnold\u202f; Oxford University Press, London; New York, NY"},{"key":"1163_CR26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, et al (2016) Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med 375:1823\u20131833. https:\/\/doi.org\/10.1056\/NEJMoa1606774","journal-title":"N Engl J Med"},{"key":"1163_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","volume":"86","author":"M Riihim\u00e4ki","year":"2014","unstructured":"Riihim\u00e4ki M, Hemminki A, Fallah M, et al (2014) Metastatic sites and survival in lung cancer. Lung Cancer Amst Neth 86:78\u201384. https:\/\/doi.org\/10.1016\/j.lungcan.2014.07.020","journal-title":"Lung Cancer Amst Neth"},{"key":"1163_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3892\/mco.2014.410","volume":"3","author":"T Tamura","year":"2015","unstructured":"Tamura T, Kurishima K, Nakazawa K, et al (2015) Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol 3:217\u2013221. https:\/\/doi.org\/10.3892\/mco.2014.410","journal-title":"Mol Clin Oncol"},{"key":"1163_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.lungcan.2013.02.006","volume":"80","author":"LEL Hendriks","year":"2013","unstructured":"Hendriks LEL, Bootsma GP, de Ruysscher DKM, et al (2013) Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain? Lung Cancer Amst Neth 80:293\u2013297. https:\/\/doi.org\/10.1016\/j.lungcan.2013.02.006","journal-title":"Lung Cancer Amst Neth"},{"key":"1163_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-319-40389-2_3","volume":"170","author":"GA Woodard","year":"2016","unstructured":"Woodard GA, Jones KD, Jablons DM (2016) Lung Cancer Staging and Prognosis. Cancer Treat Res 170:47\u201375. https:\/\/doi.org\/10.1007\/978-3-319-40389-2_3","journal-title":"Cancer Treat Res"},{"key":"1163_CR31","doi-asserted-by":"publisher","first-page":"e2037120","DOI":"10.1001\/jamanetworkopen.2020.37120","volume":"4","author":"K Sehgal","year":"2021","unstructured":"Sehgal K, Gill RR, Widick P, et al (2021) Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy. JAMA Netw Open 4:e2037120. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.37120","journal-title":"JAMA Netw Open"},{"key":"1163_CR32","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1007\/s00330-017-4779-y","volume":"27","author":"HA Vargas","year":"2017","unstructured":"Vargas HA, Veeraraghavan H, Micco M, et al (2017) A novel representation of inter-site tumour heterogeneity from pre-treatment computed tomography textures classifies ovarian cancers by clinical outcome. Eur Radiol 27:3991\u20134001. https:\/\/doi.org\/10.1007\/s00330-017-4779-y","journal-title":"Eur Radiol"},{"key":"1163_CR33","doi-asserted-by":"publisher","first-page":"7056","DOI":"10.1007\/s00330-022-08999-7","volume":"32","author":"M Zhao","year":"2022","unstructured":"Zhao M, Kluge K, Papp L, et al (2022) Multi-lesion radiomics of PET\/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma. Eur Radiol 32:7056\u20137067. https:\/\/doi.org\/10.1007\/s00330-022-08999-7","journal-title":"Eur Radiol"},{"key":"1163_CR34","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1111\/1759-7714.13681","volume":"11","author":"B Campos-Balea","year":"2020","unstructured":"Campos-Balea B, de Castro Carpe\u00f1o J, Massut\u00ed B, et al (2020) Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database. Thorac Cancer 11:3357\u20133364. https:\/\/doi.org\/10.1111\/1759-7714.13681","journal-title":"Thorac Cancer"},{"key":"1163_CR35","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/annonc\/mdz167","volume":"30","author":"J Mazieres","year":"2019","unstructured":"Mazieres J, Drilon A, Lusque A, et al (2019) Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry. Ann Oncol Off J Eur Soc Med Oncol 30:1321\u20131328. https:\/\/doi.org\/10.1093\/annonc\/mdz167","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"1163_CR36","doi-asserted-by":"publisher","first-page":"e1356145","DOI":"10.1080\/2162402X.2017.1356145","volume":"6","author":"Z-Y Dong","year":"2017","unstructured":"Dong Z-Y, Zhang J-T, Liu S-Y, et al (2017) EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer. Oncoimmunology 6:e1356145. https:\/\/doi.org\/10.1080\/2162402X.2017.1356145","journal-title":"Oncoimmunology"},{"key":"1163_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.lungcan.2017.11.009","volume":"115","author":"RA Soo","year":"2018","unstructured":"Soo RA, Lim SM, Syn NL, et al (2018) Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions. Lung Cancer Amst Neth 115:12\u201320. https:\/\/doi.org\/10.1016\/j.lungcan.2017.11.009","journal-title":"Lung Cancer Amst Neth"},{"key":"1163_CR38","doi-asserted-by":"publisher","first-page":"190052","DOI":"10.1183\/16000617.0052-2019","volume":"29","author":"N Guibert","year":"2020","unstructured":"Guibert N, Pradines A, Favre G, Mazieres J (2020) Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages. Eur Respir Rev Off J Eur Respir Soc 29:190052. https:\/\/doi.org\/10.1183\/16000617.0052-2019","journal-title":"Eur Respir Rev Off J Eur Respir Soc"},{"key":"1163_CR39","doi-asserted-by":"publisher","first-page":"E3493","DOI":"10.3390\/cancers12123493","volume":"12","author":"AB Gill","year":"2020","unstructured":"Gill AB, Rundo L, Wan JCM, et al (2020) Correlating radiomic features of heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma. Cancers 12:E3493. https:\/\/doi.org\/10.3390\/cancers12123493","journal-title":"Cancers"},{"key":"1163_CR40","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.ijrobp.2021.02.030","volume":"110","author":"SH Lee","year":"2021","unstructured":"Lee SH, Kao GD, Feigenberg SJ, et al (2021) Multiblock Discriminant Analysis of Integrative 18F-FDG-PET\/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 110:1451\u20131465. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.02.030","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1163_CR41","doi-asserted-by":"publisher","first-page":"e2203786","DOI":"10.1002\/advs.202203786","volume":"9","author":"L Wang","year":"2022","unstructured":"Wang L, Zhang M, Pan X, et al (2022) Integrative Serum Metabolic Fingerprints Based Multi-Modal Platforms for Lung Adenocarcinoma Early Detection and Pulmonary Nodule Classification. Adv Sci Weinh Baden-Wurtt Ger 9:e2203786. https:\/\/doi.org\/10.1002\/advs.202203786","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"1163_CR42","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.gpb.2022.11.003","volume":"20","author":"Y Li","year":"2022","unstructured":"Li Y, Wu X, Yang P, et al (2022) Machine Learning for Lung Cancer Diagnosis, Treatment, and Prognosis. Genomics Proteomics Bioinformatics 20:850\u2013866. https:\/\/doi.org\/10.1016\/j.gpb.2022.11.003","journal-title":"Genomics Proteomics Bioinformatics"}],"container-title":["Journal of Imaging Informatics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-024-01163-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01163-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:34:59Z","timestamp":1739460899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-024-01163-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["1163"],"URL":"https:\/\/doi.org\/10.1007\/s10278-024-01163-1","relation":{},"ISSN":["2948-2933"],"issn-type":[{"value":"2948-2933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"16 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective observational cohort study was approved by the Institutional Review Board (IRB) of Bergoni\u00e9 Institut, Bordeaux, France (September 2020). This study was performed in line with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The article does not contain any individual person\u2019s data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}